The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Opiate Receptor: Demonstration in Nervous Tissue
Pert, C. B., & Snyder, S. H. (1973) · Science · doi:10.1126/science.179.4077.1011 · Cited by 2,388
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., et al. (1995) · Nature · doi:10.1038/377532a0 · Cited by 1,912
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
Reinscheid, R. K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., & Civelli, O. (1995) · Science · doi:10.1126/science.270.5237.792 · Cited by 1,821
The neural control of micturition
Fowler, C. J., Griffiths, D., & de Groat, W. C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2401 · Cited by 1,485
CLASSIFICATION OF OPIOID RECEPTORS
PATERSON, S. J., ROBSON, L. E., & KOSTERLITZ, H. W. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071787 · Cited by 790
International Union of Pharmacology. XII. Classification of opioid receptors
Dhawan, B., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P., Portoghese, P., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Attacking pain at its source: new perspectives on opioids
Stein, C., Schäfer, M., & Machelska, H. (2003) · Nature Medicine · doi:10.1038/nm908 · Cited by 608
Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain
Pert, C. B., Pasternak, G., & Snyder, S. H. (1973) · Science · doi:10.1126/science.182.4119.1359 · Cited by 546
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Mogil, J. S., & Pasternak, G. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01502-3 · Cited by 441
Zhu, Y., King, M. A., Schuller, A. G. P., Nitsche, J. F., Reidl, M., Elde, R. P., Unterwald, E., Pasternak, G. W., & Pintar, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)80836-3 · Cited by 430
Abdelhamid, E. E., Sultana, M., Portoghese, P. S., & Takemori, A. E. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20227-0 · Cited by 427
Mechanisms underlying the recovery of urinary bladder function following spinal cord injury
de Groat, W. C., Kawatani, M., Hisamitsu, T., Cheng, C.-L., Ma, C.-P., Thor, K., Steers, W., & Roppolo, J. R. (1990) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(90)90105-r · Cited by 395
Orphanin FQ is a functional anti-opioid peptide
Mogil, J. S., Grisel, J. E., Reinscheid, R. K., Civelli, O., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00338-7 · Cited by 375
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
Jenck, F., Moreau, J.-L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., Nothacker, H.-P., & Civelli, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14854 · Cited by 347
Designing peptide receptor agonists and antagonists
Hruby, V. J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd939 · Cited by 344
A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat
Jenck, F., Wichmann, J., Dautzenberg, F. M., Moreau, J.-L., Ouagazzal, A. M., Martin, J. R., Lundstrom, K., Cesura, A. M., Poli, S. M., Roever, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090514397 · Cited by 275
Köster, A., Montkowski, A., Schulz, S., Stübe, E.-M., Knaudt, K., Jenck, F., Moreau, J.-L., Nothacker, H.-P., Civelli, O., & Reinscheid, R. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10444 · Cited by 247
A new selective antagonist of the nociceptin receptor
Guerrini, R., Calo, G., Rizzi, A., Bigoni, R., Bianchi, C., Salvadori, S., & Regoli, D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701640 · Cited by 238
From monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M.-L., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225
Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro
Connor, M., Vaughan, C. W., Chieng, B., & Christie, M. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16080.x · Cited by 225
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031.pub4 · Cited by 221
Infections resulting from narcotic addiction
Hussey, H. H., & Katz, S. (1950) · The American Journal of Medicine · doi:10.1016/0002-9343(50)90021-0 · Cited by 210
Opioid tolerance: the clinical perspective
Collett, B. J. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.58 · Cited by 207
Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQ
Reinscheid, R. K., Ardati, A., Monsma, F. J., & Civelli, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14163 · Cited by 202
Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist
Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D. G., Salvadori, S., & Regoli, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703169 · Cited by 190
Self-citationKnoflach, F., Reinscheid, R. K., Civelli, O., & Kemp, J. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06657.1996 · Cited by 181
O’Brien, J. M., Ali, N. A., Aberegg, S. K., & Abraham, E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.035 · Cited by 177
Murphy, N. P., Ly, H. T., & Maidment, N. T. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00322-3 · Cited by 173
Kuzmin, A., Sandin, J., Terenius, L., & Ögren, S. O. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041350 · Cited by 173
Antidepressant Agents for the Treatment of Chronic Pain and Depression
Jann, M. W., & Slade, J. H. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.11.1571 · Cited by 172
Ozaki, S., Kawamoto, H., Itoh, Y., Miyaji, M., Azuma, T., Ichikawa, D., Nambu, H., Iguchi, T., Iwasawa, Y., & Ohta, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00520-3 · Cited by 168
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
Murphy, N. P., & Maidment, N. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730179.x · Cited by 167
Kraus, J., Börner, C., Giannini, E., Hickfang, K., Braun, H., Mayer, P., Hoehe, M. R., Ambrosch, A., König, W., & Höllt, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107543200 · Cited by 166
Ciccocioppo, R., Economidou, D., Fedeli, A., Angeletti, S., Weiss, F., Heilig, M., & Massi, M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1645-1 · Cited by 166
Calo, G., Rizzi, A., Rizzi, D., Bigoni, R., Guerrini, R., Marzola, G., Marti, M., McDonald, J., Morari, M., Lambert, D. G., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704706 · Cited by 164
Self-citationZöllner, C., & Stein, C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_2 · Cited by 163
Dooley, C. T., Spaeth, C. G., Berzetei-Gurske, I. P., Craymer, K., Adapa, I. D., Brandt, S. R., Houghten, R. A., & Toll, L. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37095-8 · Cited by 160
A Cellular Mechanism for the Bidirectional Pain-Modulating Actions of Orphanin FQ/Nociceptin
Pan, Z. Z., Hirakawa, N., & Fields, H. L. (2000) · Neuron · doi:10.1016/s0896-6273(00)81183-6 · Cited by 158
Drugs for relapse prevention of alcoholism: ten years of progress
Spanagel, R., & Kiefer, F. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.005 · Cited by 158
Zaratin, P., Petrone, G., Sbacchi, M., Garnier, M. J., Fossati, C., Petrillo, P., Ronzoni, S., Giardina, G. A. M., & Scheideler, M. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055848 · Cited by 147
Butour, J., Moisand, C., Mazarguil, H., Mollereau, C., & Meunier, J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00919-3 · Cited by 146
Ueda, H., Yamaguchi, T., Tokuyama, S., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00832-x · Cited by 138
Peluso, J., LaForge, K. S., Matthes, H. W. D., et al. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00178-1 · Cited by 137
Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices
Nicol, B., Lambert, D. G., Rowbotham, D. J., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16007.x · Cited by 130
Self-citationEffect of nociceptin on alcohol intake in alcohol-preferring rats
Ciccocioppo, R., Panocka, I., Polidori, C., Regoli, D. C., & Massi, M. (1999) · Psychopharmacology · doi:10.1007/s002130050828 · Cited by 130
Nociceptin/Orphanin FQ Peptide Receptors: Pharmacology and Clinical Implications
Chiou, L., Liao, Y.-Y., Fan, P., Kuo, P., Wang, C.-H., Riemer, C., & Prinssen, E. P. M. (2006) · Current Drug Targets · doi:10.2174/138945007779315605 · Cited by 127
Gavioli, E. C., Marzola, G., Guerrini, R., Bertorelli, R., Zucchini, S., de Lima, T. C. M., Rae, G. A., Salvadori, S., Regoli, D. C., & Calò, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02603.x · Cited by 125
Enhanced Spinal Nociceptin Receptor Expression Develops Morphine Tolerance and Dependence
Ueda, H., Inoue, M., Takeshima, H., & Iwasawa, Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07640.2000 · Cited by 122
Economidou, D., Hansson, A. C., Weiss, F., Terasmaa, A., Sommer, W. H., Cippitelli, A., Fedeli, A., Martin-Fardon, R., Massi, M., Ciccocioppo, R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.004 · Cited by 120
Sakoori, K., & Murphy, N. P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1643-3 · Cited by 117
Zaveri, N. T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00387-4 · Cited by 113
Cellular actions of nociceptin: transduction mechanisms
Hawes, B. E., Graziano, M. P., & Lambert, D. G. (2000) · Peptides · doi:10.1016/s0196-9781(00)00232-1 · Cited by 110
Self-citationStructures That Delineate Orphanin FQ and Dynorphin A Pharmacological Selectivities
Reinscheid, R. K., Higelin, J., Henningsen, R. A., Monsma, F. J., & Civelli, O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1490 · Cited by 108
UFP‐101, a Peptide Antagonist Selective for the Nociceptin/Orphanin FQ Receptor
Calò, G., Guerrini, R., Rizzi, A., Salvadori, S., Burmeister, M. A., Kapusta, D. R., Lambert, D. G., & Regoli, D. C. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00264.x · Cited by 105
Self-citationGiannuario, A. D., Pieretti, S., Catalani, A., & Loizzo, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00579-0 · Cited by 105
Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons
Acosta, C. G., & Davies, A. M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21565 · Cited by 104
Fernandez, F., Misilmeri, M. A., Felger, J. C., & Devine, D. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300308 · Cited by 104
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
Bloms‐Funke, P., Gillen, C., Schuettler, A. J., & Wnendt, S. (2000) · Peptides · doi:10.1016/s0196-9781(00)00252-7 · Cited by 103
Gavioli, E. C., Vaughan, C. W., Marzola, G., Guerrini, R., Mitchell, V. A., Zucchini, S., de Lima, T. C. M., Rae, G. A., Salvadori, S., Regoli, D. C., et al. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0939-0 · Cited by 103
Circuitry Underlying AntiOpioid Actions of Orphanin FQ in the Rostral Ventromedial Medulla
Heinricher, M. M., McGaraughty, S., & Grandy, D. K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.6.3351 · Cited by 103
Nociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy?
Zeilhofer, H. U., & Calò, G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046979 · Cited by 101
Inoue, M., Shimohira, I., Yoshida, A., Zimmer, A., Takeshima, H., Sakurada, T., & Ueda, H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35102-x · Cited by 100
Nociceptin/orphanin FQ and drugs of abuse
Ciccocioppo, R., Angeletti, S., Panocka, I., & Massi, M. (2000) · Peptides · doi:10.1016/s0196-9781(00)00245-x · Cited by 99
Giannuario, A. D., & Pieretti, S. (2000) · Peptides · doi:10.1016/s0196-9781(00)00250-3 · Cited by 99
Spagnolo, B., Carrà, G., Fantin, M., Fischetti, C., Hebbes, C. P., McDonald, J. L., Barnes, T. A., Rizzi, A., Trapella, C., Fanton, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116764 · Cited by 99
Self-citationDautzenberg, F. M., Wichmann, J., Higelin, J., Py-Lang, G., Kratzeisen, C., Malherbe, P., Kilpatrick, G. J., & Jenck, F. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29443-x · Cited by 99
Ciccocioppo, R., Economidou, D., Rimondini, R., Sommer, W. H., Massi, M., & Heilig, M. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.006 · Cited by 98
Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801
Yamada, H., Nakamoto, H., Suzuki, Y., Ito, T., & Aisaka, K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704478 · Cited by 98
Lutfy, K., Do, T., & Maidment, N. T. (2001) · Psychopharmacology · doi:10.1007/s002130000609 · Cited by 97
Roberto, M., & Siggins, G. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601899103 · Cited by 91
Nonpeptidic Ligands for Peptide-Activated G Protein-Coupled Receptors
Blakeney, J. S., Reid, R. C., Le, G. T., & Fairlie, D. P. (2007) · Chemical Reviews · doi:10.1021/cr050984g · Cited by 90
Human Neutrophils as a Source of Nociceptin: A Novel Link between Pain and Inflammation,
Fiset, M.-É., Gilbert, C., Poubelle, P. E., et al. (2003) · Biochemistry · doi:10.1021/bi0300635 · Cited by 89
Varty, G. B., Hyde, L. A., Hodgson, R. A., Lu, S. X., McCool, M. F., Kazdoba, T. M., Vecchio, R. A. D., Guthrie, D. H., Pond, A. J., Grzelak, M. E., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0041-4 · Cited by 87
Seki, T., Awamura, S., Kimura, C., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00369-6 · Cited by 86
Kuzmin, A. V., Kreek, M. J., Bakalkin, G. Y., & Liljequist, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301169 · Cited by 85
Redrobe, J. P., Calò, G., Regoli, D. C., & Quirion, R. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0511-0 · Cited by 85
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands
Gavioli, E. C., & Calò, G. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0035-8 · Cited by 85
Loss of Antinociception Induced by Naloxone Benzoylhydrazone in Nociceptin Receptor-Knockout Mice
Noda, Y., Mamiya, T., Nabeshima, T., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18047 · Cited by 84
Kotlinska, J. H., Wichmann, J., Łęgowska, A., Rolka, K., & Silberring, J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200205000-00006 · Cited by 83
Varty, G. B., Lu, S. X., Morgan, C. A., Cohen-Williams, M. E., Hodgson, R. A., Smith‐Torhan, A., Zhang, H., Fawzi, A. B., Graziano, M. P., Ho, G. D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136937 · Cited by 81
Molecular modelling of the ORL1 receptor and its complex with nociceptin
Topham, C. M., Moulédous, L., Poda, G. I., et al. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.12.1163 · Cited by 81
The ORL1 Receptor: Molecular Pharmacology and Signalling Mechanisms
New, D. C., & Wong, Y. H. (2002) · Neurosignals · doi:10.1159/000065432 · Cited by 80
Remifentanil and Other Opioids
Servin, F. S., & Billard, V. (2008) · Springer eBooks · doi:10.1007/978-3-540-74806-9_14 · Cited by 79
Combating opiate dependence: a comparison among the available pharmacological options
Gonzalez, G. M., Oliveto, A. H., & Kosten, T. R. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.4.713 · Cited by 79
Rizzi, A., Gavioli, E. C., Marzola, G., Spagnolo, B., Zucchini, S., Ciccocioppo, R., Trapella, C., Regoli, D. C., & Calò, G. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116780 · Cited by 79
Okawa, H., Nicol, B., Bigoni, R., Hirst, R. A., Calò, G., Guerrini, R., Rowbotham, D. J., Smart, D., McKnight, A. T., & Lambert, D. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702539 · Cited by 78
Self-citationDetermination of activity for nociceptin in the mouse vas deferens
Berzetei‐Gurske, I. P., Schwartz, R. W., & Toll, L. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00238-5 · Cited by 75
Ciccocioppo, R., Economidou, D., Fedeli, A., & Massi, M. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00112-4 · Cited by 74
Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala
Meis, S., & Pape, H. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0701e.x · Cited by 73
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
Wei, G., Moss, J., & Yuan, C.-S. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00085-6 · Cited by 72
[Nphe1]nociceptin-(1–13)-NH2 antagonizes nociceptin effects in the mouse colon
Rizzi, A., Bigoni, R., Calò, G., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00730-x · Cited by 69
Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat
Obara, I., Przewłocki, R., & Przewłocka, B. (2005) · Pain · doi:10.1016/j.pain.2005.03.012 · Cited by 69
Intradermal Nociceptin Elicits Itch-Associated Responses Through Leukotriene B4 in Mice
Andoh, T., Yageta, Y., Takeshima, H., & Kuraishi, Y. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22704.x · Cited by 68
Ko, M., Wei, H., Woods, J. H., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106120 · Cited by 68
Lapalu, S., Moisand, C., Mazarguil, H., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01318-5 · Cited by 66
Endogenous Orphanin FQ/Nociceptin Is Involved in the Development of Morphine Tolerance
Chung, S., Pohl, S., Zeng, J., Civelli, O., & Reinscheid, R. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103960 · Cited by 66
Khroyan, T. V., Zaveri, N. T., Polgar, W. E., Orduna, J. M., Olsen, C. M., Jiang, F., & Toll, L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111997 · Cited by 65
Depner, U. B., Reinscheid, R. K., Takeshima, H., Brune, K., & Zeilhofer, H. U. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02676.x · Cited by 64
Sakoori, K., & Murphy, N. P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301459 · Cited by 63
Kotlinska, J. H., Rafalski, P., Biała, G., Dyląg, T., Rolka, K., & Silberring, J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02081-8 · Cited by 62
Pain management: is opioid immunosuppression a clinical problem?
Budd, K. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.06.015 · Cited by 62
Economidou, D., Fedeli, A., Martin‐Fardon, R., Weiss, F., Massi, M. N., & Ciccocioppo, R. (2006) · Peptides · doi:10.1016/j.peptides.2006.09.007 · Cited by 61
Arduin, M., Spagnolo, B., Calò, G., Guerrini, R., Carrà, G., Fischetti, C., Trapella, C., Marzola, E., McDonald, J. L., Lambert, D. G., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.026 · Cited by 61
Self-citationOuagazzal, A., Moreau, J., Pauly-Evers, M., & Jenck, F. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00066-4 · Cited by 61
Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031 · Cited by 61
Activities of mixed NOP and μ‐opioid receptor ligands
Spagnolo, B., Calò, G., Polgar, W. E., Jiang, F., Olsen, C. M., Berzetei‐Gurske, I. P., Khroyan, T. V., Husbands, S. M., Lewis, J. W., Toll, L., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707598 · Cited by 60
Recent advances towards the discovery of ORL-1 receptor agonists and antagonists
Bignan, G. C., Connolly, P. J., & Middleton, S. A. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.4.357 · Cited by 57
Shoblock, J. R. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00007.x · Cited by 52
Plasma levels on nociceptin in female fibromyalgia syndrome patients
Anderberg, U. M., Liu, Z., Berglund, L., & Nyberg, F. (1998) · Zeitschrift für Rheumatologie · doi:10.1007/s003930050241 · Cited by 50
Yamamoto, T., Shono, K., & Tanabe, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100859 · Cited by 46
The treatment of alcohol dependence
Assanangkornchai, S., & Srisurapanont, M. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280fa837d · Cited by 46
Ciccocioppo, R., Polidori, C., Antonelli, L., Salvadori, S., Guerrini, R., & Massi, M. (2002) · Peptides · doi:10.1016/s0196-9781(01)00587-3 · Cited by 45
Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys
Wakasa, Y., Fujiwara, A., Umeuchi, H., Endoh, T., Okano, K., Tanaka, T., & Nagase, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.033 · Cited by 44
Nociceptin/orphanin FQ modulates human T cell function in vitro
Waits, P., Purcell, W. M., Fulford, A. J., & McLeod, J. D. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.018 · Cited by 44
Intrathecal Opioids for Combined Spinal-Epidural Analgesia during Labour
DeBalli, P., & Breen, T. W. (2003) · CNS Drugs · doi:10.2165/00023210-200317120-00003 · Cited by 44
Xuei, X., Wetherill, L. F., Almasy, L. A., Bierut, L. J., Tischfield, J. A., Schuckit, M. A., Nürnberger, J. I., Foroud, T., & Edenberg, H. J. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00082.x · Cited by 44
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies
Varani, K., Rizzi, A., Calò, G., Bigoni, R., Tóth, G., Guerrini, R., Gessi, S., Salvadori, S., Borea, P. A., & Regoli, D. C. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900074 · Cited by 43
Huang, J., Young, B. M., Pletcher, M. T., et al. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00089.x · Cited by 35
The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia
Rizzi, A., Bigoni, R., Marzola, G., Guerrini, R., Salvadori, S., Regoli, D. C., & Calò, G. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00007 · Cited by 35
[Changes and significance of orphanin and serotonin in patients with postpartum depression].
Gu, H., Hu, D. X., Hong, X., et al. (2003) · PubMed · Cited by 33
Armstead, W. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.059 · Cited by 32 · cited 1×
“NOP activation also modulates mitogen-activated protein (MAP) kinase, extracellular signal-regulated kinase (ERK) and JUN activit”
BackgroundRole of nociceptin/orphanin FQ (Noc/oFQ) in murine experimental colitis
Kato, S., Tsuzuki, Y., Hokari, R., Okada, Y., Miyazaki, J., Matsuzaki, K., Iwai, A., Kawaguchi, A., Nagao, S., Itoh, K., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.12.006 · Cited by 31
Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats
Broccardo, M., Guerrini, R., Petrella, C., & Improta, G. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.015 · Cited by 29
Guerrini, R., Calò, G., Lambert, D. G., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040106v · Cited by 29
Self-citationAntagonism of ORL1 receptor produces an algesic effect in the rat formalin test
Yamamoto, T., Sakashita, Y., & Nozaki‐Taguchi, N. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00007 · Cited by 27
Goldfarb, Y., Reinscheid, R. K., & Kusnecov, A. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.04.008 · Cited by 27
Nociceptin/orphanin FQ prevents ethanol-induced gastric lesions in the rat
Morini, G., CARO, G. D., Guerrini, R., Massi, M., & Polidori, C. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.016 · Cited by 25
Okawa, H., Kudo, M., Kudo, T., Guerrini, R., Lambert, D. G., Kushikata, T., Yoshida, H., & MATSUKI, A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01721-9 · Cited by 24
Self-citationIs immunomodulation by opioid drugs of clinical relevance?
Welters, I. D. (2003) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-200310000-00011 · Cited by 16
Kitayama, M., McDonald, J. L., Barnes, T. A., Calò, G., Guerrini, R., Rowbotham, D. J., & Lambert, D. G. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0170-x · Cited by 14
Self-citationRecent Developments in Anxiety Disorders
Christmas, D. M., & Hood, S. D. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906778773625 · Cited by 9
Cited by
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Current Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
Averting opioid-induced respiratory depression without affecting analgesia
Dahan, A., van der Schrier, R., Smith, T., Aarts, L., van Velzen, M., & Niesters, M. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002184 · Cited by 115
Rorick-Kehn, L. M., Ciccocioppo, R., Wong, C. J., Witkin, J. M., Martinez-Grau, M. A., Stopponi, S., Adams, B. L., Katner, J. S., Perry, K. W., Toledo, M. A., et al. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13052 · Cited by 61
Podlesnik, C. A., Ko, M.-C., Winger, G., Wichmann, J., Prinssen, E. P., & Woods, J. H. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2012-7 · Cited by 40
Metadata
- Authors
- Lambert, D. G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 694-710
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1997675350
- Cited by
- 357
- References
- 133
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.